A share price of TherapeuticsMD Inc [TXMD] is currently trading at $1.25, down -14.63%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TXMD shares have gain 15.14% over the last week, with a monthly amount drifted -4.92%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
TherapeuticsMD Inc [NASDAQ: TXMD] stock has seen the most recent analyst activity on August 07, 2020, when Jefferies downgraded its rating to a Underperform. Previously, JP Morgan downgraded its rating to Neutral on May 19, 2020. On December 02, 2019, Guggenheim initiated with a Buy rating. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $7 on October 17, 2019. JP Morgan started tracking with a Overweight rating for this stock on June 15, 2018, and assigned it a price target of $11. In a note dated September 08, 2017, Morgan Stanley initiated an Equal-Weight rating and provided a target price of $6 on this stock.
TherapeuticsMD Inc experienced fluctuations in its stock price throughout the past year between $0.70 and $2.75. TherapeuticsMD Inc [NASDAQ: TXMD] shares were valued at $1.25 at the most recent close of the market.
Analyzing the TXMD fundamentals
Trailing Twelve Months sales for TherapeuticsMD Inc [NASDAQ:TXMD] were 1.60M which represents 1132.08% growth. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -3.79%, Pretax Profit Margin comes in at -2.51%, and Net Profit Margin reading is -2.08%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.12 and Total Capital is -0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1033 points at the first support level, and at 0.9517 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4733, and for the 2nd resistance point, it is at 1.6917.
Ratios To Look Out For
To put it in perspective, the Current Ratio for TherapeuticsMD Inc [NASDAQ:TXMD] is 1.64. In addition, the Quick Ratio stands at 1.64 and the Cash Ratio stands at 0.84. Considering the valuation of this stock, the price to sales ratio is 8.47, the price to book ratio is 0.53.
Transactions by insiders
Recent insider trading involved Collins Cooper C., Director, that happened on Aug 22 ’24 when 4094.0 shares were purchased. Director, Collins Cooper C. completed a deal on Aug 21 ’24 to buy 1200.0 shares.
